Chemotherapy for CLL These drugs disrupt the life cycle of cancer cells. They damage the DNA of those cells or stop them from reproducing. You get chemo in cycles that give the medicine time to work before your next dose. You may get chemo as tablets or by IV. Chemo side effects include...
IMBRUVICA® works differently from chemotherapy. This once-daily, oral medication blocks a protein in B cells called Bruton's tyrosine kinase, or BTK. For more complete information on how IMBRUVICA® works and the possible side effects, go to the How Does IMBRUVICA® Work? section.1 With...
Oncologists, or cancer doctors, stay on top of the latest in cancer care, so they can be a great resource to learn about the latest treatments (and treatments on the horizon). CLL treatments can include chemotherapy, immunotherapy, targeted medications, or a bone marrow transplant (also called...
“By combining venetoclax with drugs that can do their job within the pit lane, we thought that combinations were possible that were debilitating and would be more effective than chemotherapy.” The phase three randomized trial included over 900 youngCLLpatients from ten different countr...
Targeted Therapy:Venetoclax API's targeted mechanism of action allows it to specifically inhibit BCL-2 proteins, effectively targeting CLL cells while sparing healthy cells. This targeted approach enhances the drug's clinical efficacy, reducing the burden of chemotherapy-related side ...
Side effects of chemotherapy include hair loss, nausea, mouth sores, and increased infection risk. Tumor lysis syndrome can also occur.9 In some cases, CLL cells may be too concentrated in the bloodstream and cause circulation problems (leukostasis). Doctors may use a procedure known asleukaphere...
In children with B-cell NHL or B-AL who receive RITUXAN with chemotherapy, the most common side effects include: decreased white blood cells with fever mouth sores inflammation of the upper intestine serious infection throughout the body and organs (sepsis) ...
Diffuse Large B-Cell Lymphoma (DLBCL) as an initial treatment in combination with CHOP or other anthracycline-based chemotherapy regimens Chronic Lymphocytic Leukemia (CLL) in combination with FC chemotherapy as an initial treatment or as a treatment after disease has recurred ...
When GAZYVA is administered with chemotherapy followed by GAZYVA monotherapy, Grade 3 to 5 infections have been reported in up to 8% of patients during combination therapy, up to 13% of patients during monotherapy, and up to 8% of patients after treatment In GALLIUM, more Grade 3 to 5 ...
CHEMOTHERAPY BONE MARROW OR STEM CELL TRANSPLANT MONOCLONAL ANTIBODIES OTHER TARGETED AGENTS Targeted fixed-duration regimens are an option for people with CLL.9 Some treatment options are taken continuously until the medicine stops working, or certain side effects are observed.9 Other treatment...